All diabetes related medication will continue unaltered. Participants will be asked not to change diabetes treatment for the duration of the study. The study team will manage diabetes medication for the duration of the participant's involvement in the study. The General Practitioner (GP) or secondary care diabetes team will manage other aspects of diabetes care in line with standard clinical practice.